Cargando…

Rapid expansion of Treg cells protects from collateral colitis following a viral trigger

Foxp3(+) regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show...

Descripción completa

Detalles Bibliográficos
Autores principales: Schorer, Michelle, Lambert, Katharina, Rakebrandt, Nikolas, Rost, Felix, Kao, Kung-Chi, Yermanos, Alexander, Spörri, Roman, Oderbolz, Josua, Raeber, Miro E., Keller, Christian W., Lünemann, Jan D., Rogler, Gerhard, Boyman, Onur, Oxenius, Annette, Joller, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090079/
https://www.ncbi.nlm.nih.gov/pubmed/32251280
http://dx.doi.org/10.1038/s41467-020-15309-6
Descripción
Sumario:Foxp3(+) regulatory T (Treg) cells are essential for maintaining peripheral tolerance and preventing autoimmunity. While genetic factors may predispose for autoimmunity, additional environmental triggers, such as viral infections, are usually required to initiate the onset of disease. Here, we show that viral infection with LCMV results in type I IFN-dependent Treg cell loss that is rapidly compensated by the conversion and expansion of Vβ5(+) conventional T cells into iTreg cells. Using Vβ5-deficient mice, we show that these Vβ5(+) iTreg cells are dispensable for limiting anti-viral immunity. Rather, the delayed replenishment of Treg cells in Vβ5-deficient mice compromises suppression of microbiota-dependent activation of CD8(+) T cells, resulting in colitis. Importantly, recovery from clinical symptoms in IBD patients is marked by expansion of the corresponding Vβ2(+) Treg population in humans. Collectively, we provide a link between a viral trigger and an impaired Treg cell compartment resulting in the initiation of immune pathology.